Abstract: The invention provides a pharmaceutical composition for increasing the tensile strength of connective tissue while modifying the amount of cross-linked collagen therein comprising prolactin in an amount effective to increase the tensile strength of connective tissue as active ingredient therein in combination with a pharmacologically acceptable carrier.